Snowdome funds T-cell lymphoma study

A new study looking at treatments for T-cell lymphoma will be going ahead at Peter Mac thanks to the generosity of Snowdome donors:- the Wolf Foundation, Vision Super (proceeds from the Murray to Moyne fundraising bike ride), Mat and Gabrielle Goldsmith (proceeds from their birthday & celebratory fundraising events) and a range of anonymous donors. … Continued

Snowdome supports epigenetic BET inhibitors clinical trial

As today is International Clinical Trials Day (commemorating 20 May 1747, the day on which James Lind started his famous trial comparing treatments for scurvy), Snowdome is proud to share the following links to articles that appeared in the media today. The trial in the spotlight of all articles is supported by Snowdome funding. Consultant haematologists … Continued

recently approved research projects

Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome has worked with several passionate donors to invest over $750,000 and has successfully secured $311,000 in matched funding through the Victorian Cancer Agency. A wonderful model of ‘government & philanthropy’ … Continued

supporting ‘global best practice’

Throughout 2013/14, Snowdome was successful in joining several like-minded major donors* to establish the Centre of Research Excellence in Myeloma (CRE-M) in Melbourne. This $3million investment will support a global best practice research approach in ‘personalised or precision medicine’ which, according to reports from the U.S. and Canada, is an emerging approach for the treatment … Continued

A carer’s perspective …

Reviewing the diary of Gayle’s lymphoma now in its fifth year, I am reminded of the huge range of emotions both from the patient’s and the carer’s experience. Shock and surprise were first, when Gayle was first diagnosed with Lymphoma in the brain although she was one of the most active and vital 65 year … Continued